Wednesday, August 20, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Mixed Analyst Opinions on Lemonade LMND Stock

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_Fiscal (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of March 4, 2024, analysts have differing opinions on Lemonade (LMND) stock. Thomas McJoynt-Griffith from Keefe, Bruyette & Woods has upgraded the price target from $16 to $18 while maintaining a Market Perform rating. The consensus among eight analysts is a price target of $17.75, with estimates ranging from $9.00 to higher values. Another source has reported that Keefe, Bruyette & Woods started coverage on Lemonade with a Market Perform rating and a $24 price target.

Lemonade Inc. (LMND) Shows Strong Performance in Stock Market on March 4, 2024

On March 4, 2024, Lemonade Inc. (LMND) showed strong performance in the stock market. LMND is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating positive momentum for the stock. The price of LMND shares increased by $0.68 since the market last closed, representing a 4.19% rise from its previous closing price of $16.92. In pre-market trading on March 4, LMND continued to show strength, with the stock rising by an additional $0.09. Overall, the performance of LMND on March 4, 2024, is indicative of a strong and positive trend for the stock.

Lemonade Inc. (LMND) Stock Performance and Financial Results Analysis 2024

On March 4, 2024, Lemonade Inc. (LMND) stock performance was closely watched by investors and analysts as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, Lemonade reported a total revenue of $360.00 million for the past year, representing an impressive 86.92% increase from the previous year. However, the total revenue remained flat at $97.10 million for the fourth quarter compared to the previous quarter. Lemonade reported a net loss of -$236.90 million for the past year, which was an improvement of 20.45% compared to the previous year. In the fourth quarter, the net loss narrowed to -$42.40 million, showing a slight improvement from the previous quarter. The earnings per share (EPS) also showed positive growth, with an increase of 25.86% for the past year and remaining stable at -$0.61 for the fourth quarter. Overall, Lemonade’s financial performance for the past year and the fourth quarter demonstrated strong revenue growth and improvements in net income. Despite the net losses, the company’s EPS showed positive growth, indicating potential for future profitability. Investors and analysts will be closely monitoring Lemonade’s performance in the coming quarters to see if the company can sustain its growth trajectory and work towards achieving profitability.

Tags: LMND
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
CRWD stock news

Revolutionizing Web Design Wix Unveils AI Website Builder

Finance_ Stock Trading (2)

Anticipation for V2X Quarterly Earnings Report What Investors Need to Know

Finances

Anticipation Builds for Nuveis Quarterly Earnings Report

Recommended

EQR stock news

Significant Investment and Trading Activity at Stifel Financial Corp.: Increased Stake by Victory Capital Management Inc. and Selling Transactions by SVP Thomas B. Michaud

2 years ago
Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Analyzing Analyst Views on Snowflake NYSE SNOW

1 year ago
Finance_ Stock Charts (2)

Kaival Brands Innovations Group Implements GameChanging Reverse Stock Split to Drive Growth and Compliance

2 years ago
Healthcare-and-IT

Grifols Focuses on Deleveraging Strategy for Enhanced Financial Performance

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NIO NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Peloton’s Contradictory Signals: Insiders Sell as Institutions Buy

Viking Therapeutics Shares Plunge on Clinical Trial Safety Concerns

Broadcom Leadership Sells Holdings Amid AI-Driven Stock Surge

A Hidden Force in the AI Semiconductor Surge

The AI Arms Race: Microsoft and Alphabet’s Divergent Paths to Dominance

Key Engineer’s Departure from Altair Signals China’s Tech Ambitions

Trending

West Pharmaceutical Stock
Stocks

West Pharmaceutical Shares Defy Technical Warnings with Strong Quarterly Surge

by Robert Sasse
August 20, 2025
0

A fascinating divergence is playing out in West Pharmaceutical's stock performance. Despite technical indicators flashing warning signs...

SK TelecomADR Stock

Can AI Growth Offset Core Weakness at SK Telecom?

August 20, 2025
CSX Stock

Activist Investor Ramps Up Pressure on CSX Board Amid Rail Industry Shakeup

August 20, 2025
Peloton Stock

Peloton’s Contradictory Signals: Insiders Sell as Institutions Buy

August 20, 2025
Viking Therapeutics Stock

Viking Therapeutics Shares Plunge on Clinical Trial Safety Concerns

August 20, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • West Pharmaceutical Shares Defy Technical Warnings with Strong Quarterly Surge August 20, 2025
  • Can AI Growth Offset Core Weakness at SK Telecom? August 20, 2025
  • Activist Investor Ramps Up Pressure on CSX Board Amid Rail Industry Shakeup August 20, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com